Health care startups in Hangzhou, China
Updated 16 Nov 2026
Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Company | City | Last round | Amount | Date |
|---|---|---|---|---|
| AusperBio | Hangzhou | Series C | $120.0M | 2026-08-27 |
| METiS Pharmaceuticals | Hangzhou | Series D | $55.7M | 2025-08-04 |
| LYNK Pharmaceuticals | Hangzhou | Series C | $16.7M | 2023-09-21 |
| Barty Medical | Hangzhou | Series D | $29.5M | 2026-09-23 |
| DXY | Hangzhou | Series E | $500.0M | 2020-12-29 |
| Prime Lifescience | Hangzhou | Series A | $14.7M | 2026-06-30 |
| DIAGENS | Hangzhou | Series C | $14.1M | 2023-12-29 |
| Qihan Biotech | Hangzhou | Series B | $16.0M | 2023-09-15 |
8 rows of the CSV in 5 of its 18 columns.
- The 295 health care startups in Hangzhou, China have raised $6.0B in total.
- 50 of them closed their most recent round in the last 12 months, $580.0M combined.
- The largest of those rounds is AusperBio's $120.0M Series C, dated August 2026.
- The most recent is Rhino Medical's $15.0M Series B on 6 November 2026.
- Puhua Capital is an investor in 7 of them, more than any other fund.
- Biotech is the most common other sector, with 108 companies (37%).
- 33% were founded in 2020 or later; the median founding year is 2016.
- The most common team size is 11 to 50 employees (42% of companies with a recorded size).
- 1 is a unicorn, valued at $1 billion or more.
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Newest rounds
12 of 295| Company | What they do | Sector | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|
| Barty Medical | Barty Medical provides hospital healthcare services to patients. | Health care | Series D | $29.5M | 2026-09-23 | $46.7M | Shenzhen Guozhong Venture Capital Management, Sinowisdom, Sunz Fund | 101 to 250 | 2015 |
| AusperBio | AusperBio develops oligonucleotide therapeutics and targeted delivery technologies for treating diseases. | Biotech | Series C | $120.0M | 2026-08-27 | $357.0M | Qiming Venture Partners, BioVenture, Hankang Capital +1 | 51 to 100 | 2019 |
| Prime Lifescience | Prime Lifescience develops a big data platform for life sciences research and analysis. | Biotech | Series A | $14.7M | 2026-06-30 | $44.5M | Qiming Venture Partners, Qiji Investment, Ennovation Ventures | 11 to 50 | 2021 |
| Dishi Medical | Dishi Medical manufactures ophthalmic medical devices and micro-assisted robots supported by biotechnology. | Biotech | Series A | $13.7M | 2026-01-19 | $13.7M | Hillhouse Investment, Fortune Venture Capital, Linear Capital +1 | 11 to 50 | 2021 |
| SonoSilicon | SonoSilicon researches medical-grade micro-on-chip ultrasound systems and chip design. | Health care | Seed | $5.5M | 2025-12-11 | $5.5M | Qiming Venture Partners | 11 to 50 | 2023 |
| Healsun Biopharm | Healsun Biopharm provides antibody and recombinant protein CRO and CDMO services. | Biotech | Series C | $27.8M | 2025-11-19 | $101.3M | Yinxinggu Capital, Haitong Capital, Dongfang Jiafu +2 | 251 to 500 | 2015 |
| METiS Pharmaceuticals | METiS Pharmaceuticals is an AI-driven drug formulation company. | Artificial intelligence | Series D | $55.7M | 2025-08-04 | $391.7M | Source Code Capital, Frees Fund, Luminous Ventures (former Lightspeed China Partners) | 51 to 100 | 2020 |
| DIAGENS | DIAGENS is a Hangzhou-based biotechnology firm that provides in-vitro diagnostic products and medical equipment. | Biotech | Series C | $14.1M | 2023-12-29 | Shenzhen Guozhong Venture Capital Management, Haiyuan Capital, China Venture Capital HRVC +2 | 51 to 100 | 2014 | |
| LYNK Pharmaceuticals | LYNK Pharmaceuticals is a biotech company that discovers and develops new medicines. | Biotech | Series C | $16.7M | 2023-09-21 | Legend Capital, Kaitai Capital, New Alliance Capital +2 | 11 to 50 | 2018 | |
| Qihan Biotech | Qihan Biotech develops gene-editing technology for organ transplantation. | Biotech | Series B | $16.0M | 2023-09-15 | $116.3M | Matrix Partners China, Northern Light Venture Capital, CMB International Capital Corporation +1 | 101 to 250 | 2017 |
| DXY Unicorn | DXY is an online healthcare community connecting doctors, consumers, and healthcare organizations. | Biotech | Series E | $500.0M | 2020-12-29 | $682.0M | Shunwei Capital, DCM Ventures, Legend Capital +1 | 101 to 250 | 2000 |
| Malgo | Malgo offers integrated digital health solutions to enterprises. | Artificial intelligence | Angel | $1.6M | 2018-03-15 | TusStar, Future Capital Discovery Fund, Tusholdings | 1 to 10 | 2017 |
Table 1. Health care startups in Hangzhou, China: the 12 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 295.
Largest rounds
Last 12 months| # | Company | What they do | Sector | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | AusperBio | AusperBio develops oligonucleotide therapeutics and targeted delivery technologies for treating diseases. | Biotech | Series C | $120.0M | 2026-08-27 | $357.0M | Qiming Venture Partners, BioVenture, Hankang Capital +1 | 51 to 100 | 2019 |
| 2 | Barty Medical | Barty Medical provides hospital healthcare services to patients. | Health care | Series D | $29.5M | 2026-09-23 | $46.7M | Shenzhen Guozhong Venture Capital Management, Sinowisdom, Sunz Fund | 101 to 250 | 2015 |
| 3 | Healsun Biopharm | Healsun Biopharm provides antibody and recombinant protein CRO and CDMO services. | Biotech | Series C | $27.8M | 2025-11-19 | $101.3M | Yinxinggu Capital, Haitong Capital, Dongfang Jiafu +2 | 251 to 500 | 2015 |
| 4 | Prime Lifescience | Prime Lifescience develops a big data platform for life sciences research and analysis. | Biotech | Series A | $14.7M | 2026-06-30 | $44.5M | Qiming Venture Partners, Qiji Investment, Ennovation Ventures | 11 to 50 | 2021 |
| 5 | Dishi Medical | Dishi Medical manufactures ophthalmic medical devices and micro-assisted robots supported by biotechnology. | Biotech | Series A | $13.7M | 2026-01-19 | $13.7M | Hillhouse Investment, Fortune Venture Capital, Linear Capital +1 | 11 to 50 | 2021 |
| 6 | SonoSilicon | SonoSilicon researches medical-grade micro-on-chip ultrasound systems and chip design. | Health care | Seed | $5.5M | 2025-12-11 | $5.5M | Qiming Venture Partners | 11 to 50 | 2023 |
Table 2. Health care startups in Hangzhou, China: the 6 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most active investors
By companies backed| # | Investor | Type | Location | Companies | Share | Funded, 12 months | Latest |
|---|---|---|---|---|---|---|---|
| 1 | Puhua Capital | Venture capital firm | Hangzhou, China | 7 | 2% | ||
| 2 | Qiming Venture Partners | Venture capital firm | Shanghai, China | 5 | 2% | 3 | AusperBio, Prime Lifescience, SonoSilicon |
| 3 | Yinxinggu Capital | Venture capital firm | Hangzhou, China | 5 | 2% | 1 | Healsun Biopharm |
| 4 | Fortune Venture Capital | Venture capital firm | Shenzhen, China | 4 | 1% | 1 | Dishi Medical |
| 5 | Source Code Capital | Venture capital firm | Chaoyang, China | 3 | 1% | ||
| 6 | Sinowisdom | Venture capital firm | Hangzhou, China | 3 | 1% | 1 | Barty Medical |
| 7 | ZSVC | Private equity firm | Beijing, China | 3 | 1% | ||
| 8 | Blue Bay Ventures | Venture capital firm | California City, United States | 3 | 1% | ||
| 9 | BioVenture | Venture capital firm | Suzhou, China | 2 | 1% | 1 | AusperBio |
| 10 | Lilly Asia Ventures | Venture capital firm | Shanghai, China | 2 | 1% | ||
| 11 | Legend Capital | Venture capital firm | Beijing, China | 2 | 1% | ||
| 12 | Shenzhen Guozhong Venture Capital Management | Venture capital firm | Shenzhen, China | 2 | 1% | 1 | Barty Medical |
| 13 | Qiji Investment | Venture capital firm | Suzhou, China | 2 | 1% | 1 | Prime Lifescience |
| 14 | China Venture Capital HRVC | Private equity firm | Nanjing, China | 2 | 1% | ||
| 15 | Haiyuan Capital | Venture capital firm | Shenzhen, China | 2 | 1% |
Table 3. Health care startups in Hangzhou, China: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Sectors
Table 4. Health care startups in Hangzhou, China by sector. Source: FundingWatcher. Data as of 16 November 2026.
Funding stage
Table 5. Health care startups in Hangzhou, China by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Rounds by month
| Rounds by month | Companies | Share | Raised |
|---|---|---|---|
| November 2026 | 1 | 2% | $15.0M |
| October 2026 | 2 | 4% | $4.5M |
| September 2026 | 6 | 12% | $60.7M |
| August 2026 | 3 | 6% | $161.6M |
| June 2026 | 5 | 10% | $59.0M |
| May 2026 | 5 | 10% | $32.0M |
| April 2026 | 4 | 8% | $23.8M |
| March 2026 | 5 | 10% | $18.7M |
| February 2026 | 2 | 4% | $28.8M |
| January 2026 | 3 | 6% | $35.2M |
| December 2025 | 10 | 20% | $28.4M |
| November 2025 | 4 | 8% | $112.1M |
Table 6. Health care startups in Hangzhou, China: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most recent round by year
| Most recent round by year | Companies | Share | Raised |
|---|---|---|---|
| 2026 | 36 | 12% | $439.5M |
| 2025 | 48 | 16% | $421.8M |
| 2024 | 29 | 10% | $118.3M |
| 2023 | 36 | 12% | $266.5M |
| 2022 | 28 | 9% | $123.0M |
| 2021 | 24 | 8% | $838.3M |
Table 7. Health care startups in Hangzhou, China by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Founding year
| Founding year | Companies | Share |
|---|---|---|
| 2023 or later | 27 | 9% |
| 2020 to 2022 | 69 | 24% |
| 2015 to 2019 | 113 | 39% |
| 2010 to 2014 | 63 | 22% |
| Before 2010 | 21 | 7% |
Table 8. Health care startups in Hangzhou, China by founding year. Source: FundingWatcher. Data as of 16 November 2026.
Team size
| Team size | Companies | Share |
|---|---|---|
| 1 to 10 | 19 | 8% |
| 11 to 50 | 98 | 42% |
| 51 to 100 | 46 | 20% |
| 101 to 250 | 39 | 17% |
| 251 to 500 | 16 | 7% |
| 501 to 1,000 | 9 | 4% |
| 1,001 to 5,000 | 4 | 2% |
Table 9. Health care startups in Hangzhou, China by headcount. Source: FundingWatcher. Data as of 16 November 2026.
Method
- A company is on this list when Health care is one of its sectors and its headquarters is in Hangzhou, China. On 16 November 2026 that is 295 companies.
- Stage, round, amount and date are those of the company's most recent funding round. Amounts are in US dollars as the source records them.
- The table prints the 12 newest rounds whose row is complete: a one-sentence description, a city, a named fund and an amount. The CSV carries all 295 rows: 118 have no round amount, 0 no city and 107 no website. The CSV carries domain, website, LinkedIn and the cached description sentence where present.
Sources, fields and exclusions of both files: Method.
Questions
- How many health care startups in Hangzhou, China are on the list?
- 295, in the file dated 16 November 2026. 50 of them closed their most recent round in the last 12 months.
- What does the CSV contain?
- One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
- How much does the list cost?
- $29 one-time for all 295 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
- What arrives after payment?
- At once: the CSV download link, on the page after payment and by mail.
- Can I see rows before buying?
- The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.